Lumida
/SILA
⌘K
Sila Realty Trust Inc

Sila Realty Trust Inc

SILA
$30.36USD↑+0.00%+0.00 today

MARKET CAP

1.7B

P/E (TTM)

45.3x

FWD P/E

—

DAY RANGE

$30 – $30

52W RANGE

$30
$30

AI Summary

Stalk
StalkMedium

Although SILA remains in a robust Stage 2 advance with an active Parabola pattern and long-/medium-term uptrends intact, price has become extremely extended above rising EMAs and sits in overbought territory. Under a Stable strategy emphasizing durability and low-volatility entries, it’s prudent to defer new longs until a pullback into the rising 9/21 EMAs or prior resistance zone near the mid-26 area offers a clearer, lower-risk entry point.

  • ↑FY25 cash NOI hit $169.9M, up 0.8% YoY from higher rents and interest income.
  • ↑Liquidity stands above $480M and net debt/EBITDA is 3.9×, enabling disciplined acquisitions.
  • ↓AFFO per share declined 5.8% YoY due to increased interest expenses from swaps.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Cielo Realty Trust, Inc. (NASDAQ: CELA) operates as a real estate investment trust (REIT) primarily focusing on acquiring and managing healthcare facilities across the United States. Its strategy emphasizes long-term net leases in necessity-driven healthcare properties, ensuring stable, predictable income streams during times of economic uncertainty. Positioned in the healthcare real estate sector, CELA is well-aligned with the demographic trends associated with the aging population and increasing outpatient healthcare services demand.

Bull says

  • ↑FY25 cash NOI hit $169.9M, up 0.8% YoY from higher rents and interest income.
  • ↑Liquidity stands above $480M and net debt/EBITDA is 3.9×, enabling disciplined acquisitions.
  • ↑Completed six acquisitions (~$150M) in 2025, all anchored by investment-grade tenants.
  • ↑EBITDARM coverage ratio improved to 5.9× from 5.3×, indicating strong tenant operations.
  • ↑Investment-grade tenant mix rose to 40.6%, enhancing income stability.
  • ↑AFFO payout ratio at 74% with strong debt coverage supports reinvestment strategy.

Bear says

  • ↓AFFO per share declined 5.8% YoY due to increased interest expenses from swaps.
  • ↓Loss of tenants such as Alexandria Healthcare facility highlights potential revenue gaps.
  • ↓Asset pricing has tightened, possibly squeezing future acquisition yield spreads.
  • ↓Uncertain impact from healthcare legislation (e.g., 'One Big Beautiful Bill') threatens cash flows.
  • ↓Share buyback plans may compete with capex, risking liquidity constraints.
  • ↓Rising rates and tenant turnover could offset demographic demand tailwinds.

Investment themes with SILA

Residential REITs↑ +0.00%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 07-17-2026neutral

Transcript signals

Bull points

  • From a 2025 outlook perspective, we've generally said as an indication, we're targeted to grow the enterprise roughly between 7.5% and 15% per annum.
  • We do have a very near-term pipeline that we're executing that we hope to be able to speak more about in the not-too-distant future.
  • I am pleased to report an extremely positive quarter to end 2024, capping one of the most eventful years in CLS history.

Bear points

  • I think some of that has quelled a little bit, as you can probably imagine, with the latest outlook given by the Fed as well as by some of the economic reads of inflation.
  • the transaction market, when you kind of look at on-market type transactions did slow a bit going into the end of the year.
  • I do think we are on track around acquisitions for the numbers that Michael walked through on a full year basis.
Read full transcript analysis ›